Kaleido Biosciences

About Kaleido Biosciences

Kaleido Biosciences is a biotechnology company focused on developing novel microbiome therapies to address a range of metabolic, immune, and infectious diseases. The company operates in the healthcare and pharmaceutical markets, primarily serving patients and healthcare providers. Kaleido's business model revolves around the research and development of microbiome-based treatments, leveraging its proprietary Microbiome Metabolic Therapies (MMT) platform. This platform enables the company to rapidly design and develop therapies that modulate the microbiome to treat specific diseases. Kaleido generates revenue through partnerships, collaborations, and licensing agreements with other pharmaceutical companies and healthcare organizations. The company also aims to advance its pipeline of proprietary drug candidates through clinical trials, ultimately seeking regulatory approval and commercialization.